Introduction
Pneumocystis carinii pneumonia(PCP) is the most common opportunistic infection in acquired immunodeficiency syndrome. Diagnosis is established with the demonstration of typical oocytes in respiratory secretions, particularly in bronchoalveolar lavage fluid (sensitivity >95%) (1) . However, in patients with severe respiratory failure, bronchoscopy with bronchoalveolar lavage is dangerous. Recently, polymerase chain reaction (PCR) on induced sputum has become an alternative diagnostic and monitoring method (2) . In addition,
measurement of plasma (1->3)~P-D-glucan (G-test) has been
shown to be useful in the diagnosis and monitoring ofPCP (3) . Wepresent a case of PCP diagnosed and monitored with both PCRon sputum and G-test on plasma.
Case Report
A 35-year-old South African man was admitted to Kyushu University Hospital on October 8, 1996, because of severe pneumonia. In June 1996, the patient began to lose appetite and weight, and on September 25, high fever and cough developed. The patient was admitted to a local hospital. Hewas administered several antibiotics, including piperacillin and minocycline, however these antibiotics were not effective, and the patient was transferred to KyushuUniversity Hospital on October 8. The patient had contracted malaria in 1988, and denied any risk factors for human immunodeficiency virus (HIV) infection. He had smoked about 20 cigarettes per day for the past 5 years. Family history was unremarkable. Bodytemperature was 39°C, pulse was 96 beats per minute, and respiratory rate was 40 perminute. Blood pressure was 1 10/ 80 mmHg. Oxygen was administered at a rate of4 //min by face mask. Analysis of arterial blood gas showed that the partial pressure of oxygen was 53.9 mmHg,the partial pressure of carbon dioxide was 27.2 mmHg,and pH was 7.412. Physical examination showedslightly anemic conjunctiva, white-coated tongue, and bilateral diffuse fine crackles over the lung bases.
Blood laboratory tests were performed ( Plasma p-D-glucan and PCR on Sputum in PCP Imaging studies suggested that the most likely diagnosis was an interstitial pneumonia, such as that due to Pneumocystis carinii or cytomegalovirus. Bronchoalveolar lavage was attempted, but was not tolerated by the patient. Trimethoprim and sulfamethoxazole (TMP/SMX) at 160 mg/800 mg every 8 hours with glucocorticoid therapy was empirically started on October 9. (One gram of methylprednisolone daily for the first 3 days, followedby 80 mg ofprednisolone daily for 2 days. The prednisolone was gradually tapered.) Sputum culture yielded no bacteria. Sputum cytology revealed no protozoa. PCRson sputum for Mycobacteriumtuberculosis and Mycobacterium aviumcomplexwerenegative. However, Pneumocystiscarinii was detected in sputum with PCR, and the plasma (l-^3)-p-Dglucan level was increased to 272.6 pg/ml on G-test (Seikagaku Co., Tokyo). Blood culture yielded no bacteria or fungus. Plasma cytomegaloviral antigenemia and serum immunoglobulin G (IgG) and immunoglobulin M(IgM) to Cytomegalovirus were negative. Based on the above findings, PCP was diagnosed on October 21. On October 15, 1 week after TMP/SMX and glucocorticoid were started, arterial blood gas analysis and plain chest X-ray films showed marked improvement. On October 25, 2 weeks after the start of treatment, respiratory symptoms, such as cough, sputum, and dyspnea had mostly resolved, and the partial pressure of oxygen was 82.9 mmHgon room air despite the remaining infiltration on plain chest X-ray films, and a positive PCRfor Pneumocystis carinii in sputum.
At the same time, the plasma (l->3)-(3-D-glucan level decreased to 67.9 pg/ml and further to 49.1 pg/ml on November 1. On November 5, chest CT still showed infiltration (Fig. 3) , and PCRfor Pneumocystis carinii in sputum was positive. On November 14, chest CT showed no active infiltrations (Fig. 4) . On November15, PCRon sputum became negative for Pneumocystis carinii in sputum (2); however, it also detects dead Pneumocystis carinii, producing false-positive results (5).
On the other hand, according to the recent evidence that Pneumocystis carinii mightbe a fungus (6), ( l ->3)-(3-D-grucan, which composes a portion of the cell wall of most fungi, has becomea new marker for Pneumocystis carinii infection (3). In our patient, both PCRon sputum and the G-test were used to monitor PCP during treatment (Fig. 5) . Results of both studies paralleled clinical and radiographic improvement of PCP. Before treatment, plasma (1^3)-p-D-glucan was high (272.6 pg/ml) and PCR on sputum was positive for Pneumocystis carinii. Then, the plasma (l -^3)-(3-D-glucan level rapidly fell from 272.6 pg/ml to 70 pg/ml during the first 2 weeks of treatment, parallel to clinical and radiographic improvement. However, for the next 3 weeks, the plasma (l->3)-(3-D-glucan level was almost unchanged despite further clinical and radiographic improvement. WhenPCRon sputum for Pneumocystis carinii became negative, the plasma level of (1->3)-p-Dglucan (70.5 pg/ml) was still higher than normal (<10 pg/ml)
.
This sustained elevation of ( 1 -^3)-(3-D-glucan despite negative PCRresults might be due to another subclinical deep fungal infection. However, the patient had only oral candidiasis which resolved with fluconazole, and blood culture showed no fungemia. Yasuokaet al also reported that six patients with PCP showed decreases in plasma (1^3)-(3-D-glucan levels to 50% or less of peak levels with clinical improvement (3). These In summary, the combination of PCRfor Pneumocystis carinii on sputum and the G-test is useful in the diagnosis and monitoring of PCP, especially when bronchoalveolar lavage cannot be done. In our patient, the plasma (1->3)-(3-D-glucan level decreased to about one-fourth that before treatment, although it remained higher than normal when the PCRon sputum became negative for Pneumocystis carinii.
